Inam Butt and the eye-drop doping case: a silver medal that no prescription could save

The silver medal from the April 2026 Asian Beach Games is still sitting in Inam Butt's cabinet, but by every signal in the investigation file, it no longer belongs to him. Pakistan's former beach wrestling world champion faces a suspension of roughly two months, backdated to April, after the International Testing Agency (ITA) accepted that the medication he used was for eye treatment rather than performance enhancement. It sounds like a soft landing for a veteran athlete. But read the file closely, and the issue is not whether Inam Butt is guilty or innocent. It is a procedural gap any athlete can fall into: a valid Therapeutic Use Exemption, or TUE, has to come first, not after. Domestic media are pushing the story under a relief-is-coming headline. I see an athlete-administrator paying the price for the one thing he should have controlled best: his own paperwork. To anyone following amateur wrestling, Inam Butt is no stranger. He once held a beach wrestling world title, a relatively young discipline inside the United World Wrestling (UWW) system. The competitive pyramid there is narrower than freestyle or Greco-Roman, but a world title is still a real achievement, enough for a nation to treat him as an icon and enough for his name to appear on every honours board. Alongside his competitive career, Inam Butt has shifted toward administration. He is a national squad coach, secretary of the Pakistan Wrestling Federation (PWF), and chairman of the Pakistan Olympic Association (POA) athletes commission. Three roles in one person: athlete, coach, official. That power structure explains why this case draws attention far beyond an ordinary doping sanction. An amateur athlete caught in a doping case can be a personal story. A federation official caught while holding an executive seat is an institutional story. And that is exactly where things get complicated. Notably, the investigation is not being handled by the Pakistani federation. The ITA, operating under the World Anti-Doping Code (WADA) framework, is running the case. That detail matters. It means the outcome is hard to bend under national pressure, and any framing about patriotism or local particularities has no place. Read the sequence of events closely and this is a procedural case, not a performance case. Authorities accepted that the detected substance came from eye medication. They accepted it was a genuine medical need, not organized cheating. And yet a violation still stands. Because Inam Butt did not secure the TUE before using the medication. This is what outsiders often get wrong. Under anti-doping rules, using medication for a legitimate reason does not automatically exempt you. You have to prove beforehand, with paperwork, that the drug is necessary and does not create a competitive advantage. If the paperwork arrives late, you still violate, however sound the medical basis. The difference between innocent and exempt is not whether you are sick, but when you filed. The file also reveals a striking detail: the ITA is reported to have granted permission for the medication for around a year. That creates an internal contradiction. If a one-year permission truly existed, why would a failure to secure the TUE in time exist at all? The two facts can only reconcile in one of two ways: the permission covered a different window or substance, or it was granted retroactively after the fact. Either way, the problem sits in paperwork handling, not in intent to cheat. On sanction, the figure mentioned, roughly two months backdated to April, fits the reduced bracket for no significant fault or negligence. It is not a full exoneration. If the ITA found no fault at all, the penalty would be a reprimand with no period of ineligibility. Two months tells us the panel credited the medical context but still assigned partial responsibility to the athlete. And here is the part few reports emphasize enough: medal stripping follows from strict liability and is largely independent of the medical finding. However legitimate the reason for the medication, results from the violation window are annulled. The April 2026 Asian Beach Games silver is gone, and no medical argument brings it back. Timing is the next point worth discussing. Backdating the sanction to April suggests the positive sample dates to around the Asian Beach Games. That means his entire competitive cycle around that moment is called into question. Not because he cheated, but because his paperwork could not keep pace with his competition calendar. The most comfortable hypothesis for Inam Butt is that he is the victim of a rigid paperwork system that should be more flexible toward genuine medical needs. That hypothesis has merit. But it ignores an uncomfortable fact: he is the person in the room who knows the TUE rules best. He is not an eighteen-year-old rookie at his first international meet. He is a former world champion, a national squad coach, a federation board member. In that position, his responsibility sits above the minimum. A young athlete forgetting a TUE can be forgiven. A federation official forgetting a TUE is harder to justify, because he is the one who is supposed to remind others of that duty. This is the sharpest point domestic media are avoiding. The eye-medication story is moving, but it does not erase the question of governance competence. If a man who competes, administers and coaches lets a basic detail slip, the problem is not with him as an individual. It sits in the role-concentration structure he embodies. Small federations often bundle many roles into a few people because of thin staffing. But that concentration creates two risks at once. First, a multi-hat holder struggles to separate responsibility when something goes wrong. Second, when it does go wrong, the credibility of the whole institution is dragged along. Inam Butt voluntarily stepped down from his PWF secretary seat and his POA athletes commission chairmanship while awaiting the ruling. The move is sound governance, but it is also an admission that one cannot be under investigation and hold an executive seat at the same time. I could be wrong here. If the ITA proves the fault lies entirely with the governing body, for instance if TUE information was delayed on the federation side, then Inam Butt is a man caught inside a broken process. In that case the two-month sanction is still an undeserved stain. But until the ITA issues its formal decision, both scenarios remain open. The ITA's formal decision is expected within a week. If it lands as reported, Inam Butt remains eligible for the Asian Games and keeps his coaching role. The silver medal does not come back. The thing worth watching is not the two-month sanction. It is whether this case forces small federations to separate the roles of athlete, coach and official away from a single person. Because if a former world champion can still let a therapeutic exemption slip, how many young talents behind him are getting it right?